Compounds > arginine

arginine and carbostyril

arginine has been researched along with carbostyril in 13 studies

Research

Studies (13)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's7 (53.85)18.2507
2000's2 (15.38)29.6817
2010's4 (30.77)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abe, K; Hashimoto, J; Imai, Y; Minami, N1
Kessler, T; Lugnier, C1
Abe, Y; Fujisawa, Y; Miyanaka, H; Miyatake, A; Mori, N; Yube, K1
Chu, CP; Jin, QH; Kannan, H; Kato, K; Oiso, Y; Qiu, DL; Yu, NS1
Bax, BD; Brown, KK; Chan, PF; Eggleston, DS; Fosberry, A; Gentry, DR; Giordano, I; Gorrec, F; Gwynn, MN; Hann, MM; Hennessy, A; Hibbs, M; Huang, J; Jones, E; Jones, J; Lewis, CJ; May, EW; Pearson, ND; Saunders, MR; Shen, C; Shillings, A; Singh, O; Spitzfaden, CE; Theobald, AJ; Wohlkonig, A1
Medico, CJ; Walsh, P1
Kim, KY; Kwak, HS; Park, JH; Woo, GJ1
Ahmadi, S; Bartlett, C; Bear, CE; Gonska, T; Ip, W; Jiang, J; Laselva, O; Lew, A; Moraes, TJ; Ouyang, H; Wellhauser, L; Wu, YS; Xia, S1
Kmiec, EB; To, RQ1
Chung, IK; Gootz, TD; McGuirk, PR; Muller, MT; Spitzner, JR1
Chu, DT; Clement, JJ; Permana, PA; Plattner, JJ; Shen, LL; Snapka, RM1
Coughlin, SA; Evans, AC; Huff, AC; Rake, JB; Robinson, RG; Selander, KN; Wentland, MP1
Gruger, T; Heisig, P; Maxwell, A; Nitiss, JL; Pommier, Y; Seeber, S; Strumberg, D; Zechiedrich, EL1

Reviews

1 review(s) available for arginine and carbostyril

ArticleYear
Pharmacotherapy in the critically ill obese patient.
    Critical care clinics, 2010, Volume: 26, Issue:4

    Topics: Aminoglycosides; Antithrombins; Arginine; Body Mass Index; Carbapenems; Cephalosporins; Drug Dosage Calculations; Enoxaparin; Fibrinolytic Agents; Heparin; Humans; Hypnotics and Sedatives; Lipopeptides; Obesity; Oxazolidinones; Penicillins; Pipecolic Acids; Protein C; Quinolones; Recombinant Proteins; Safety; Sulfonamides; Vancomycin

2010

Other Studies

12 other study(ies) available for arginine and carbostyril

ArticleYear
Contribution of vascular nitric oxide to basal blood pressure in conscious spontaneously hypertensive rats and normotensive Wistar Kyoto rats.
    Clinical science (London, England : 1979), 1995, Volume: 89, Issue:2

    Topics: Animals; Antihypertensive Agents; Arginine; Blood Pressure; Captopril; Endothelium, Vascular; Heart Rate; Hypertension; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Pentolinium Tartrate; Piperidines; Quinolones; Rats; Rats, Inbred SHR; Rats, Inbred WKY

1995
Rolipram increases cyclic GMP content in L-arginine-treated cultured bovine aortic endothelial cells.
    European journal of pharmacology, 1995, Jul-18, Volume: 290, Issue:2

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Analysis of Variance; Animals; Aorta; Arginine; Cattle; Cells, Cultured; Cyclic AMP; Cyclic GMP; Drug Interactions; Endothelium, Vascular; Exonucleases; Indomethacin; Nitric Oxide; Phosphodiesterase Inhibitors; Pyrrolidinones; Quinolones; Rolipram

1995
Role of nitric oxide in regulation of renal sympathetic nerve activity during hemorrhage in conscious rats.
    The American journal of physiology, 1999, Volume: 277, Issue:1

    Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine; Blood Pressure; Consciousness; Enzyme Inhibitors; Heart Rate; Hemorrhage; Kidney; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Piperidines; Quinolones; Rats; Rats, Sprague-Dawley; Sympathetic Nervous System

1999
Enhanced cardiovascular alteration and Fos expression induced by central salt loading in a conscious rat transgenic for the metallothionein-vasopressin fusion gene.
    Neuroscience research, 2005, Volume: 53, Issue:2

    Topics: Animals; Animals, Genetically Modified; Antidiuretic Hormone Receptor Antagonists; Arginine; Brain; Cardiovascular System; Consciousness; Immunohistochemistry; Injections, Intraventricular; Male; Metallothionein; Oncogene Proteins v-fos; Piperidines; Quinolones; Rats; Rats, Sprague-Dawley; Receptors, Vasopressin; Recombinant Fusion Proteins; Saline Solution, Hypertonic; Sodium Chloride; Vasopressins

2005
Type IIA topoisomerase inhibition by a new class of antibacterial agents.
    Nature, 2010, Aug-19, Volume: 466, Issue:7309

    Topics: Anti-Bacterial Agents; Apoenzymes; Arginine; Aspartic Acid; Binding Sites; Catalytic Domain; Ciprofloxacin; Crystallography, X-Ray; DNA; DNA Cleavage; DNA Gyrase; DNA, Superhelical; Drug Design; Drug Resistance; Escherichia coli; Manganese; Models, Molecular; Protein Conformation; Quinolines; Quinolones; Staphylococcus aureus; Structure-Activity Relationship; Topoisomerase II Inhibitors

2010
Characterization of the quinolone resistance mechanism in foodborne Salmonella isolates with high nalidixic acid resistance.
    International journal of food microbiology, 2011, Mar-15, Volume: 146, Issue:1

    Topics: Anti-Infective Agents; Arginine; DNA Gyrase; DNA Topoisomerase IV; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Food Microbiology; Meat; Microbial Sensitivity Tests; Mutation; Nalidixic Acid; Plasmids; Quinolones; Republic of Korea; Salmonella enterica

2011
ORKAMBI-Mediated Rescue of Mucociliary Clearance in Cystic Fibrosis Primary Respiratory Cultures Is Enhanced by Arginine Uptake, Arginase Inhibition, and Promotion of Nitric Oxide Signaling to the Cystic Fibrosis Transmembrane Conductance Regulator Channe
    Molecular pharmacology, 2019, Volume: 96, Issue:4

    Topics: Aminophenols; Aminopyridines; Animals; Arginase; Arginine; Benzodioxoles; Bronchi; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Cytosol; Drug Combinations; Humans; Intestinal Mucosa; Mice; Mutation; Nitric Oxide; Nose; Quinolones

2019
Assembly of transcriptionally active chromatin in vitro: a possible role for topoisomerase II.
    Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research, 1990, Volume: 1, Issue:1

    Topics: Adenosine Triphosphate; Animals; Anti-Infective Agents; Cell-Free System; Chromatin; DNA Topoisomerases, Type II; DNA, Circular; DNA, Superhelical; Enrofloxacin; Fluoroquinolones; Gene Expression Regulation; Models, Genetic; Nucleosomes; Quinolones; Teniposide; Topoisomerase II Inhibitors; Transcription, Genetic; Xenopus laevis

1990
Analysis of eukaryotic topoisomerase II cleavage sites in the presence of the quinolone CP-115,953 reveals drug-dependent and -independent recognition elements.
    Molecular pharmacology, 1995, Volume: 48, Issue:2

    Topics: Amsacrine; Anti-Infective Agents; Base Sequence; DNA; DNA Topoisomerases, Type II; Etoposide; Fluoroquinolones; Humans; Hydrolysis; Molecular Sequence Data; Quinolones; Teniposide; Topoisomerase II Inhibitors

1995
Quinobenoxazines: a class of novel antitumor quinolones and potent mammalian DNA topoisomerase II catalytic inhibitors.
    Biochemistry, 1994, Sep-20, Volume: 33, Issue:37

    Topics: Animals; Antineoplastic Agents; Camptothecin; Cattle; Cell Line; Chlorocebus aethiops; DNA Replication; Doxorubicin; Kidney; Kinetics; Oxazines; Quinolones; Simian virus 40; Structure-Activity Relationship; Teniposide; Thymus Gland; Topoisomerase II Inhibitors

1994
DNA sequence preferences at sites cleaved by human DNA topoisomerase II in response to novel quinolone derivatives.
    Anti-cancer drug design, 1995, Volume: 10, Issue:3

    Topics: Amsacrine; Base Sequence; DNA; DNA Topoisomerases, Type II; HeLa Cells; Humans; Hydrolysis; Molecular Sequence Data; Quinolones; Substrate Specificity; Teniposide; Topoisomerase II Inhibitors

1995
A mutation in Escherichia coli DNA gyrase conferring quinolone resistance results in sensitivity to drugs targeting eukaryotic topoisomerase II.
    Antimicrobial agents and chemotherapy, 2004, Volume: 48, Issue:12

    Topics: Anti-Bacterial Agents; Chromosome Mapping; DNA Gyrase; DNA, Superhelical; Drug Resistance, Bacterial; Enzyme Inhibitors; Escherichia coli; Etoposide; Microbial Sensitivity Tests; Mutagenesis, Site-Directed; Plasmids; Point Mutation; Quinolones; Reverse Transcriptase Polymerase Chain Reaction; Teniposide; Time Factors; Topoisomerase II Inhibitors

2004